| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/14/2008 | CN101176708A Carmofur sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176707A Carmustine sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176706A Temperature control sustained-release injection containing resist metabolism series medicine |
| 05/14/2008 | CN100387724C Method for preparing extract of sophorae fructus containing high concentration of aglycone by hot water extraction |
| 05/14/2008 | CN100387716C Preparation of KTV series products for inhibiting tumor cell growth and use |
| 05/14/2008 | CN100387713C Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
| 05/14/2008 | CN100387710C Therapy for primary and metastatic cancers |
| 05/14/2008 | CN100387706C Epothilone -a microtubule stabilizer for treating tumor and blood vessel restenosis |
| 05/14/2008 | CN100387703C Fatly phospho embrella Pa-I.H bacterial strain and method of culturing fatty phospho embrella and medicine made from its active component |
| 05/14/2008 | CN100387621C Production of antihuman antigen receptors and use thereof |
| 05/14/2008 | CN100387619C Regulatory/unfolding peptides of ezrin |
| 05/14/2008 | CN100387616C Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/14/2008 | CN100387609C Novel antibiotic preparing process |
| 05/14/2008 | CN100387603C Eremophil dilactone natural product with tumour cell growth inhibiting activity |
| 05/14/2008 | CN100387602C Chelerythrine compound and its preparing method |
| 05/14/2008 | CN100387597C Amide substituted imidazopyridines |
| 05/14/2008 | CN100387589C Flavanone compound and uses thereof |
| 05/14/2008 | CN100387587C Process for separating purifying actived tea polyphenols |
| 05/14/2008 | CN100387302C Folacin-starch nanometer granule, its preparation method and application |
| 05/14/2008 | CN100387292C Chinese medicine preparation for treating leukemia |
| 05/14/2008 | CN100387279C Chinese medicine preparation for treating malignant tumor |
| 05/14/2008 | CN100387275C Oral Chinese medicine composition for treating malignant tumor |
| 05/14/2008 | CN100387262C Hedyotis herba powder injection |
| 05/14/2008 | CN100387243C Quality control method of ixeris sonchifolia injection |
| 05/14/2008 | CN100387240C An extract of faeces bombycis |
| 05/14/2008 | CN100387234C Medicine containing forrest silk vine root orherb aglycone, and its preparing method and use |
| 05/14/2008 | CN100387226C Cepharanthine oral disintegration tablet and its preparing method |
| 05/14/2008 | CN100387126C Method of increasing content of flavonoids and phenolic substances in plants |
| 05/13/2008 | US7371845 MAGE-A3 peptides presented by HLA class II molecules |
| 05/13/2008 | US7371835 p53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 05/13/2008 | US7371832 Polynucleotides encoding molecules associated with cell proliferation |
| 05/13/2008 | US7371826 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 05/13/2008 | US7371820 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371813 Method for use of IGF-binding protein for selective sensitization of target cells in vivo |
| 05/13/2008 | US7371780 For combination with taxanes and anthracyclines; photodynamic therapy; for uterine/breast cancer |
| 05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
| 05/13/2008 | US7371773 2-(3,4-dimethoxy-phenyl)-3-(4-hydroxy-phenyl)-acrylonitrile; drug transporter, which actively transports an anticancer drug out of cancer cells, antagonist; improve drug resistance; anticarcinogenic agent; enhance bioavailability of anticancer drug |
| 05/13/2008 | US7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371753 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2008 | US7371750 Compounds and compositions as protein kinase inhibitors |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371742 Destroying tumor, viruses, bacteria cells ; retinoblastmas therapy |
| 05/13/2008 | US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability |
| 05/13/2008 | US7371543 Factor VII or VIIa-like molecules |
| 05/13/2008 | US7371404 Amphoteric liposomes and their use |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371382 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 05/13/2008 | US7371379 Epidermal growth factors (ErbB2); gene expression inhibition; anticancer agents |
| 05/13/2008 | US7371373 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 05/13/2008 | US7371371 Interleukin-2 mutants with reduced toxicity |
| 05/13/2008 | US7371370 Using colony stimulating factor comprising amino acid sequence variation as therapeutic tools in treatment and prevention of hematopoietic, neurological or reproduction disorders |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2360833C Reovirus for the treatment of cellular proliferative disorders |
| 05/13/2008 | CA2323414C Cytostatic agents |
| 05/13/2008 | CA2315239C Nucleotide and protein sequence of mammastatin and methods of use |
| 05/13/2008 | CA2255856C Therapeutic uses for an aminosterol compound |
| 05/13/2008 | CA2234794C Novel antiproliferative protein from bacillus thuringiensis var. thuringiensis |
| 05/13/2008 | CA1341573C Recombinant gamma interferons having enhanced stability and methods therefor |
| 05/08/2008 | WO2008055233A1 Protein kinase inhibitors |
| 05/08/2008 | WO2008054749A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| 05/08/2008 | WO2008054702A1 Anilinopiperazine derivatives and methods of use thereof |
| 05/08/2008 | WO2008054701A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| 05/08/2008 | WO2008054639A2 Use of a catechin or polyphenol to treat ocular diseases and infection |
| 05/08/2008 | WO2008054594A2 Method for controlling angiogenesis in animals |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008053909A1 Agent for controlling growth and/or differentiation of mesenchymal stem cell |
| 05/08/2008 | WO2008053863A1 Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton |
| 05/08/2008 | WO2008053861A1 Novel compound having 1,4-benzoxazin-3-one skeleton |
| 05/08/2008 | WO2008053812A1 Cyanopyridine derivative and medicinal use thereof |
| 05/08/2008 | WO2008053579A1 Antigenic polypeptide usable as therapeutic agent for malignant neoplasm |
| 05/08/2008 | WO2008053573A1 Remedy for malignant neoplasm |
| 05/08/2008 | WO2008053517A1 Agent for promoting in vivo dha synthesis and seaweed oil |
| 05/08/2008 | WO2008053319A1 Amide resorcinol compounds |
| 05/08/2008 | WO2008053301A2 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 05/08/2008 | WO2008053219A2 Composition for the treatment of gastrointestinal diseases |
| 05/08/2008 | WO2008053157A1 Aminoheteroaryl compounds as for the treatment of diseases mediated by c-met kinase activity |
| 05/08/2008 | WO2008053136A1 2-(hetero-)aryl,4-carbonyl substituted pyrazole derivatives as inhibitors of p38 mitogen-activated protein kinase |
| 05/08/2008 | WO2008053025A1 Therapeutic use of gba2 |
| 05/08/2008 | WO2008052974A1 3-amino-pyrazole-4-carboxamide derivatives useful as inhibitors of protein kinases |
| 05/08/2008 | WO2008052931A1 A method of administering an antitumor compound |
| 05/08/2008 | WO2008052733A1 Imidazopyridazines as pi3k lipid kinase inhibitors |
| 05/08/2008 | WO2008052628A1 Triazabenzo[e]azulene derivatives for the treatment of tumors |
| 05/08/2008 | WO2008052444A1 Compounds with a six-membered heterocyclic ring, their preparing method and pharmaceutical use |
| 05/08/2008 | WO2008052441A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof |
| 05/08/2008 | WO2008052322A1 Immunotoxγn fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers |
| 05/08/2008 | WO2008052279A1 Organo-arsenoxide compounds and use thereof |
| 05/08/2008 | WO2008052277A1 Crystalline composition of gm-csf/gm-csfr |
| 05/08/2008 | WO2008052238A1 Treatment of urological cancer |
| 05/08/2008 | WO2008039359A3 Bicyclic pyrimidine kinase inhibitors |
| 05/08/2008 | WO2008036308A3 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith |
| 05/08/2008 | WO2008035365A8 Rna interference mediated inhibition of aurorakinase b and its combinations as anticancer therapy |
| 05/08/2008 | WO2008026040A3 68ga-labeled peptide-based radiopharmaceuticals |
| 05/08/2008 | WO2008024301A8 Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma |
| 05/08/2008 | WO2008016192A3 Fused heterocyclic derivative and use thereof |